The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor-on-a-chip Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 PDX Model
1.2.3 CDX Model
1.3 Market by Application
1.3.1 Global Tumor-on-a-chip Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor-on-a-chip Market Perspective (2018-2029)
2.2 Tumor-on-a-chip Growth Trends by Region
2.2.1 Global Tumor-on-a-chip Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tumor-on-a-chip Historic Market Size by Region (2018-2023)
2.2.3 Tumor-on-a-chip Forecasted Market Size by Region (2024-2029)
2.3 Tumor-on-a-chip Market Dynamics
2.3.1 Tumor-on-a-chip Industry Trends
2.3.2 Tumor-on-a-chip Market Drivers
2.3.3 Tumor-on-a-chip Market Challenges
2.3.4 Tumor-on-a-chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor-on-a-chip Players by Revenue
3.1.1 Global Top Tumor-on-a-chip Players by Revenue (2018-2023)
3.1.2 Global Tumor-on-a-chip Revenue Market Share by Players (2018-2023)
3.2 Global Tumor-on-a-chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor-on-a-chip Revenue
3.4 Global Tumor-on-a-chip Market Concentration Ratio
3.4.1 Global Tumor-on-a-chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor-on-a-chip Revenue in 2022
3.5 Tumor-on-a-chip Key Players Head office and Area Served
3.6 Key Players Tumor-on-a-chip Product Solution and Service
3.7 Date of Enter into Tumor-on-a-chip Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor-on-a-chip Breakdown Data by Type
4.1 Global Tumor-on-a-chip Historic Market Size by Type (2018-2023)
4.2 Global Tumor-on-a-chip Forecasted Market Size by Type (2024-2029)
5 Tumor-on-a-chip Breakdown Data by Application
5.1 Global Tumor-on-a-chip Historic Market Size by Application (2018-2023)
5.2 Global Tumor-on-a-chip Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tumor-on-a-chip Market Size (2018-2029)
6.2 North America Tumor-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tumor-on-a-chip Market Size by Country (2018-2023)
6.4 North America Tumor-on-a-chip Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor-on-a-chip Market Size (2018-2029)
7.2 Europe Tumor-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tumor-on-a-chip Market Size by Country (2018-2023)
7.4 Europe Tumor-on-a-chip Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor-on-a-chip Market Size (2018-2029)
8.2 Asia-Pacific Tumor-on-a-chip Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tumor-on-a-chip Market Size by Region (2018-2023)
8.4 Asia-Pacific Tumor-on-a-chip Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor-on-a-chip Market Size (2018-2029)
9.2 Latin America Tumor-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tumor-on-a-chip Market Size by Country (2018-2023)
9.4 Latin America Tumor-on-a-chip Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor-on-a-chip Market Size (2018-2029)
10.2 Middle East & Africa Tumor-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tumor-on-a-chip Market Size by Country (2018-2023)
10.4 Middle East & Africa Tumor-on-a-chip Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellesce
11.1.1 Cellesce Company Detail
11.1.2 Cellesce Business Overview
11.1.3 Cellesce Tumor-on-a-chip Introduction
11.1.4 Cellesce Revenue in Tumor-on-a-chip Business (2018-2023)
11.1.5 Cellesce Recent Development
11.2 Daxiang Biotech
11.2.1 Daxiang Biotech Company Detail
11.2.2 Daxiang Biotech Business Overview
11.2.3 Daxiang Biotech Tumor-on-a-chip Introduction
11.2.4 Daxiang Biotech Revenue in Tumor-on-a-chip Business (2018-2023)
11.2.5 Daxiang Biotech Recent Development
11.3 Mimetas
11.3.1 Mimetas Company Detail
11.3.2 Mimetas Business Overview
11.3.3 Mimetas Tumor-on-a-chip Introduction
11.3.4 Mimetas Revenue in Tumor-on-a-chip Business (2018-2023)
11.3.5 Mimetas Recent Development
11.4 InSphero
11.4.1 InSphero Company Detail
11.4.2 InSphero Business Overview
11.4.3 InSphero Tumor-on-a-chip Introduction
11.4.4 InSphero Revenue in Tumor-on-a-chip Business (2018-2023)
11.4.5 InSphero Recent Development
11.5 Hepregen
11.5.1 Hepregen Company Detail
11.5.2 Hepregen Business Overview
11.5.3 Hepregen Tumor-on-a-chip Introduction
11.5.4 Hepregen Revenue in Tumor-on-a-chip Business (2018-2023)
11.5.5 Hepregen Recent Development
11.6 Charles River
11.6.1 Charles River Company Detail
11.6.2 Charles River Business Overview
11.6.3 Charles River Tumor-on-a-chip Introduction
11.6.4 Charles River Revenue in Tumor-on-a-chip Business (2018-2023)
11.6.5 Charles River Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details